Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Ferguson

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Journal of Interventional Cardiology|June 18, 2002
Low molecular weight heparins and glycoprotein IIb/IIIa antagonistsJames J Ferguson
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 20, 2006
The role of oral antiplatelet agents in atherothrombotic diseaseJames J Ferguson
Circulation|August 15, 2002
Meeting highlights: highlights of the 51st annual scientific sessions of the American College of Cardiology. Atlanta, Georgia, USA. March 17-20, 2002James J Ferguson
Clinical Cardiology|November 14, 2002
Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarctionJames J Ferguson
Texas Heart Institute Journal|May 21, 2005
2004: that was the year that wasJames J Ferguson
Texas Heart Institute Journal|June 18, 2003
The times, they ARE a changin'James J Ferguson
Future Cardiology|October 7, 2009
Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy--CLARITY-TIMI 28James J Ferguson
Texas Heart Institute Journal|November 26, 2004
Retroactive indexing: the apotheosis of a laboratory bulletin?James J Ferguson
Circulation|March 31, 2004
If there's smoke, is there fire?James J Ferguson
Texas Heart Institute Journal|April 23, 2008
A word from the dark sideJames J Ferguson
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of Interventional Cardiology|June 18, 2002
Low molecular weight heparins and glycoprotein IIb/IIIa antagonistsJames J Ferguson
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 20, 2006
The role of oral antiplatelet agents in atherothrombotic diseaseJames J Ferguson
Circulation|August 15, 2002
Meeting highlights: highlights of the 51st annual scientific sessions of the American College of Cardiology. Atlanta, Georgia, USA. March 17-20, 2002James J Ferguson
Clinical Cardiology|November 14, 2002
Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarctionJames J Ferguson
Texas Heart Institute Journal|May 21, 2005
2004: that was the year that wasJames J Ferguson
Texas Heart Institute Journal|June 18, 2003
The times, they ARE a changin'James J Ferguson
Future Cardiology|October 7, 2009
Clopidogrel plus aspirin in patients with acute myocardial infarction treated with fibrinolytic therapy--CLARITY-TIMI 28James J Ferguson
Texas Heart Institute Journal|November 26, 2004
Retroactive indexing: the apotheosis of a laboratory bulletin?James J Ferguson
Circulation|March 31, 2004
If there's smoke, is there fire?James J Ferguson
Texas Heart Institute Journal|April 23, 2008
A word from the dark sideJames J Ferguson
Pageof 7